These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 632750)

  • 1. Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E.
    Bartholomew RM; Esser AF; Müller-Eberhard HJ
    J Exp Med; 1978 Mar; 147(3):844-53. PubMed ID: 632750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.
    Cooper NR; Jensen FC; Welsh RM; Oldstone MB
    J Exp Med; 1976 Oct; 144(4):970-84. PubMed ID: 62019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in activation of human and guinea pig complement by retroviruses.
    Bartholomew RM; Esser AF
    J Immunol; 1978 Nov; 121(5):1748-51. PubMed ID: 213489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitation of the membrane attack complex of complement in an air-driven ultracentrifuge.
    Bartholomew RM; Podack ER; Esser AF
    J Immunol Methods; 1979; 31(3-4):351-60. PubMed ID: 521635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41.
    Ebenbichler CF; Thielens NM; Vornhagen R; Marschang P; Arlaud GJ; Dierich MP
    J Exp Med; 1991 Dec; 174(6):1417-24. PubMed ID: 1744579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complement activation and biological activities].
    Inoue K
    Nihon Saikingaku Zasshi; 1976 Jul; 31(4):535-55. PubMed ID: 988219
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of moloney murine leukaemia virus proteins: an assay for hydrophobic protein-protein interactions.
    Andersen KB
    J Gen Virol; 1982 Jan; 58 Pt 1():83-93. PubMed ID: 7142970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moloney leukemia virus-induced cell surface antigen: detection and characterization in sodium dodecyl sulfate gels.
    Troy FA; Fenyö EM; Klein G
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5270-4. PubMed ID: 74831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes.
    Hammer CH; Shin ML; Abramovitz AS; Mayer MM
    J Immunol; 1977 Jul; 119(1):1-8. PubMed ID: 559700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C5b-9 dimer: isolation from complement lysed cells and ultrastructural identification with complement-dependent membrane lesions.
    Biesecker G; Podack ER; Halverson CA; Müller-Eberhard HJ
    J Exp Med; 1979 Feb; 149(2):448-58. PubMed ID: 762498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deviated lysis: transfer of complement lytic activity to unsensitized cells. IV. Parital isolation of the activity.
    Hänsch G; Rother U; Rother K
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):48-59. PubMed ID: 868206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of retroviral vector particles in human blood through complement inhibition.
    Rother RP; Squinto SP; Mason JM; Rollins SA
    Hum Gene Ther; 1995 Apr; 6(4):429-35. PubMed ID: 7612700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1 fixation and classical complement pathway activation by a fragment of the Cmu4 domain of IgM.
    Hurst MM; Volanakis JE; Stroud RM; Bennett JC
    J Exp Med; 1975 Nov; 142(5):1322-6. PubMed ID: 1194853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
    Rollins SA; Sims PJ
    J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide.
    Green N; Shinnick TM; Witte O; Ponticelli A; Sutcliffe JG; Lerner RA
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6023-7. PubMed ID: 6947213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
    Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
    J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reactivity of the complement system.
    Hadding U
    Monogr Allergy; 1977; 12():36-45. PubMed ID: 335218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.